This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Gastrointestinal Diseases  • Liver/ Biliary Tract/ Pancreatic Diseases  • Blood/ Coagulation  • Colon Cancer  • Oncology, Other  • Hepatobiliary Surgery  • Alert me on articles by topic

M. Margaret Kemeny, MD

Arch Surg. 2008;143(4):401.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The use of hepatic resection for metastatic colorectal cancer has grown enormously during the past few decades. Because of data compiled from numerous centers throughout the world, it has become clear that patients with 1 to 3 hepatic metastases will be cured with a hepatic resection 30% of the time. No chemotherapy can offer comparable statistics. Furthermore, there are no data to suggest that taking out a lobe or a full segment is superior to just removing the metastases as long as the margin is 1 cm.

Many new instruments have been developed to help with hepatic resections by reducing bleeding. Among them have been the CUSA ultrasonic surgical aspiration system, harmonic scalpel, and others. The introduction of such instruments has generally come after laboratory research and marketing on the part of the manufacturers. Actual studies of the clinical usefulness of these instruments, such as the . . . [Full Text of this Article]

AUTHOR INFORMATION

RELATED ARTICLE

Liver Resection With a New Multiprobe Bipolar Radiofrequency Device
Ahmet Ayav, Long Jiao, Robert Dickinson, Joanna Nicholls, Miroslav Milicevic, Ricardo Pellicci, Philippe Bachellier, and Nagy Habib
Arch Surg. 2008;143(4):396-401.
ABSTRACT | FULL TEXT